Bank Of Oklahoma National Association / »

Mineralys Therapeutics shares owned by Bank Of Oklahoma National Association /

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Bank Of Oklahoma National Association / from 13F filings

Historical chart of Bank Of Oklahoma National Association / investment in Mineralys Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.001322322.5323323.53242424.52525.526
Value ($)Share countHistorical MLYS position of Bank Of Oklahoma … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Bank Of Oklahoma National Association / consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Bank Of Oklahoma National Association /

Quarter filed Position value Share count Share price at filing
2024-09-30 $323 25 12.92

More positions owned by Bank Of Oklahoma National Association /

Ishares Russell 1000 Etf common (IWB)
Vanguard S&p 500 Etf common (VOO)
Apple common (AAPL)
Exxon Mobil Corp common (XOM)
Microsoft Corp common (MSFT)
Nvidia Corp common (NVDA)
Ishares Core S&p Midcap Etf common (IJH)
Vanguard Ftse Emerging Markets common (VWO)
Amazon.com common (AMZN)
Spdr S&p 500 Etf Trust Etf common (SPY)
Ishares Core S&p Small-cap 600 common (IJR)
Aaon common (AAON)
Ishares Msci Eafe Etf common (EFA)
Ishares Core S&p 500 Etf common (IVV)
Jpmorgan Chase & Co common (JPM)

View all positions for Bank Of Oklahoma National Association /

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics